Cite
Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.
MLA
Lellek, Heinrich, et al. “Caspofungin plus Posaconazole as Salvage Therapy of Invasive Fungal Infections in Immunocompromised Patients.” Mycoses, vol. 54, Jan. 2011, pp. 39–44. EBSCOhost, https://doi.org/10.1111/j.1439-0507.2010.01985.x.
APA
Lellek, H., Waldenmaier, D., Dahlke, J., Ayuk, F. A., Wolschke, C., Kröger, N., & Zander, A. R. (2011). Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients. Mycoses, 54, 39–44. https://doi.org/10.1111/j.1439-0507.2010.01985.x
Chicago
Lellek, Heinrich, Dirk Waldenmaier, Joachim Dahlke, Francis Ayketang Ayuk, Christine Wolschke, Nicolaus Kröger, and Axel R. Zander. 2011. “Caspofungin plus Posaconazole as Salvage Therapy of Invasive Fungal Infections in Immunocompromised Patients.” Mycoses 54 (January): 39–44. doi:10.1111/j.1439-0507.2010.01985.x.